Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/26/2025

Management of Septated Hepatic Cysts

Diagnostic Approach

  • The American Association for the Study of Liver Diseases recommends obtaining an MRI to characterize septated hepatic cysts and assess for worrisome features that would suggest a mucinous cystic neoplasm (MCN) requiring surgical resection, with a specificity of 94-98% when multiple features are present 1, 2
  • MRI is the preferred modality for characterizing septated hepatic cysts, as it is more accurate than CT in identifying worrisome features, with a specificity of 94-98% when multiple features are present 1, 2
  • The combination of >1 major feature (such as thick septations or nodularity) PLUS >1 minor feature (such as upstream biliary dilatation, thin septations, internal hemorrhage, perfusional changes, or fewer than 3 coexistent hepatic cysts) carries 94-98% specificity for MCN and warrants surgical resection 1, 2

Management Pathways

  • If MRI shows worrisome features (≥1 Major + ≥1 Minor), proceed directly to surgical resection with complete excision, as this is the gold standard for suspected MCNs, with a risk of invasive carcinoma of 3-6% and high recurrence rates with incomplete resection 6, 2, 3
  • If MRI shows simple cyst with hemorrhage, conservative management is appropriate, with presentation typically including heterogeneous hyperechoic mobile material (clots) on ultrasound, hyperintense internal septations on T1-weighted MRI, and lack of enhancement on contrast-enhanced ultrasound 4, 5

Clinical Context Considerations

  • MCNs predominantly occur in middle-aged women and typically present in the left liver lobe, with symptoms in 86% of cases (pain, fullness, early satiety), and tumor markers CEA and CA 19-9 may be elevated in MCNs, particularly with invasive carcinoma 1, 3